Old Web
English
Sign In
Acemap
>
Paper
>
P616 IBD reference and biosimilar adalimumab CroSS over study (iBaSS): design considerations and methodology
P616 IBD reference and biosimilar adalimumab CroSS over study (iBaSS): design considerations and methodology
2020
David Young
U Freudensprung
C Harris
R Harris
J Harvey
J. Addison
S Latter
Fraser Cummings
Keywords:
Intensive care medicine
Adalimumab
Crossover study
Physical therapy
Medicine
Biosimilar
Biosimilar Pharmaceuticals
cost savings
injection site
Disease remission
Medical physics
treatment outcome
Visual analogue pain scale
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]